EYOUGENE
Latest round
- Series B
Last raised
- Jan 2023
Total raised
- Undisclosed
Investors
- 2
About EYOUGENE
Based in Shanghai, China, and established in 2016, EYOUGENE is a biotechnology company that provides contract development and manufacturing organization (CDMO) services, and intermediates for medicals and materials. It has R&D centers in Shanghai, Xi'an, and Wuhan, and Shanghai R&D centres cover over 10,000 square meters. And it has production bases and formulation R&D platforms in Gansu, Shandong, Shanxi, Jiangxi, and other places. Moreover, it has additional branches in Shenzhen, Germany, and the USA., and Johnson & Johnson. And its material clients include BASF SE, NICCA, and Mitsubishi Chemical. EYOUGENE provides CDMO services for medicals and materials. The new materials include furandicarboxylic acid and 2-Hydroxy-6-naphthoic acid. The furandicarboxylic acid is used for packaging containers, barrier films, fiber materials, and bulletproof glass, and 2-Hydroxy-6-naphthoic acid is used for engineering plastics, organic pigments, and pharmaceutical organic intermediates. Biomedical include antiviral drugs, antitumor drugs, calciferol drugs, and hypoglycemic drugs.
Who invested in EYOUGENE
2 investors across 1 round
See all investors in EYOUGENE
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jan 12, 2023
Amount
Undisclosed
Investors
Questions about EYOUGENE
Who invested in EYOUGENE?
EYOUGENE has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has EYOUGENE raised?
EYOUGENE has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did EYOUGENE last raise money?
EYOUGENE's most recent round on record is a Series B, in Jan 2023.
What does EYOUGENE do?
Based in Shanghai, China, and established in 2016, EYOUGENE is a biotechnology company that provides contract development and manufacturing organization (CDMO) services, and intermediates for medicals and materials.
Where is EYOUGENE headquartered?
EYOUGENE is headquartered in Shanghai, China.
Which VCs invest in companies like EYOUGENE?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at EYOUGENE's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like EYOUGENE? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.